Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
archive
arena pharmaceuticals
avapritinib
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
cancer
cardiovascular disease
colorectal cancer
cstone pharmaceuticals
deals
detroit blog main
detroit top stories
eisai
eli lilly
europe blog main
europe top stories
european medicines agency
fisogatinib
flatiron health
genentech
hepatocellular carcinoma
indiana blog main
indiana top stories
investing
jeff albers
lorcaserin
lung cancer
medical
What
cancer
3
×
fda
marketing
3
×
drug
advisory
approval
blood
blueprint
candidate
company
concerns
currently
different
drugs
eisai
flags
fluid
higher
hydrochlorothiazide
incidence
irbesartan
j
lorcaserin
loss
lupin
market
medicine
medicines
muscle
new
pact
particular
patients
pharmaceuticals
post
pressure
published
pulls
recall
recalled
Language
unset
Current search:
marketing
×
cancer
×
@slashgear.com
2 years ago
Blood pressure and fluid retention drugs recalled over cancer concerns
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks